Citation: | BIAN Yun, BAI Hailong, MENG Xiaofeng, LIU Xiao, XUE Chao, LIU Ruixue, CHANG Hongkun, TIAN Fengsheng, CUI Ronggang, SU Yang, LIU Mei. Correlation between dynamic changes of cytokines and condition of disease in patients with simple diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(4): 61-65. DOI: 10.7619/jcmp.20222162 |
To explore the correlation between dynamic changes of cytokines and condition of disease in patients with simple diabetic retinopathy (DR).
A total of 222 patients with simple DR in authors' hospital from October 2020 to March 2021 were prospectively selected as the research objects, and they were divided into proliferative diabetic retinopathy (PDR) group and non-PDR group according to the disease outcome after a year of follow up. General materials and cytokine levels were compared between the two groups, and the multivariate Logistic regression model was used to analyze the related factors affecting the condition of disease in patients with simple DR.
Up to April, 2022, 5 cases were lost during follow-up, and 217 cases were finally included, with a follow-up rate of 97.75%; among the 217 cases, 61 cases (28.11%) with PDR were selected as PDR group, and 156 cases (71.89%) without PDR were selected as non-PDR group. There were significant differences in the change rates of serum vascular endothelial growth factor (VEGF), interleukin-18 (IL-18) and interleukin-1β (IL-1β) between the two groups (P < 0.05). Multivariate Logistic regression analysis showed that change rate of after 1 year follow-up and according to the outcome of the disease vascular endothelial growth factor VEGF (OR=1.054, 95%CI, 1.047 to 1.061), change rate of IL-18 (OR=1.163, 95%CI, 1.150 to 1.175) and change rate of IL-1β (OR= 1.132, 95%CI, 1.120 to 1.144) were the risk factors for the progression of simple DR (P < 0.001).
The dynamic changes of VEGF, IL-1β and IL-18 are related to the change of disease in patients with simple DR.
[1] |
李雪, 张萍. 糖尿病视网膜病变的临床治疗新进展[J]. 国际眼科杂志, 2019, 19(1): 69-72. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201901018.htm
|
[2] |
王曼丽, 贾竹敏, 付留俊, 等. 2型糖尿病患者并发糖尿病视网膜病变的影响因素分析[J]. 临床内科杂志, 2022, 39(1): 47-49. https://www.cnki.com.cn/Article/CJFDTOTAL-LCLZ202201016.htm
|
[3] |
RAMAN K S, MATSUBARA J A. Dysregulation of the NLRP3 inflammasome in diabetic retinopathy and potential therapeutic targets[J]. Ocular Immunol Inflamm, 2022, 30(2): 470-478. doi: 10.1080/09273948.2020.1811350
|
[4] |
MENINI S, IACOBINI C, VITALE M, et al. The inflammasome in chronic complications of diabetes and related metabolic disorders[J]. Cells, 2020, 9(8): 1812. doi: 10.3390/cells9081812
|
[5] |
LOUKOVAARA S, PⅡPPO N, KINNUNEN K, et al. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy[J]. Acta Ophthalmol, 2017, 95(8): 803-808. doi: 10.1111/aos.13427
|
[6] |
中华医学会糖尿病学分会视网膜病变学组. 糖尿病视网膜病变防治专家共识[J]. 中华糖尿病杂志, 2018, 10(4)241-247
|
[7] |
FU Z J, WANG Z X, LIU C H, et al. Fibroblast growth factor 21 protects photoreceptor function in type 1 diabetic mice[J]. Diabetes, 2018, 67(5): 974-985. doi: 10.2337/db17-0830
|
[8] |
ARRIGO A, ARAGONA E, BANDELLO F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy[J]. Ann Med, 2022, 54(1): 1089-1111. doi: 10.1080/07853890.2022.2064541
|
[9] |
FRIEDRICH J, STEEL D H W, SCHLINGEMANN R O, et al. MicroRNA expression profile in the vitreous of proliferative diabetic retinopathy patients and differences from patients treated with anti-VEGF therapy[J]. Trans Vis Sci Tech, 2020, 9(6): 16. doi: 10.1167/tvst.9.6.16
|
[10] |
MOHD-ILHAM I, TAI E L M, SUHAIMI H, et al. Evaluation of macular and retinal nerve fiber layer thickness in children with type 1 diabetes mellitus without retinopathy[J]. Korean J Ophthalmol, 2021, 35(4): 287-294. doi: 10.3341/kjo.2020.0106
|
[11] |
SUGIMOTO K, MURAKAMI H, DEGUCHI T, et al. Cutaneous microangiopathy in patients with type 2 diabetes: impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy[J]. J Diabetes Investig, 2019, 10(5): 1318-1331. doi: 10.1111/jdi.13020
|
[12] |
CVITKOVIC K, SESAR A, SESAR I, et al. Concentrations of selected cytokines and vascular endothelial growth factor in aqueous humor and serum of diabetic patients[J]. Semin Ophthalmol, 2020, 35(2): 126-133. doi: 10.1080/08820538.2020.1755320
|
[13] |
SHEN F, LIU D. The effects of cytokine polymorphisms on predisposition to microvascular complications of diabetes mellitus: a meta-analysis[J]. Int Arch Allergy Immunol, 2021, 182(11): 1103-1112.
|
[14] |
KUO C Y J, MURPHY R, RUPENTHAL I D, et al. Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum-a systematic review[J]. BMC Ophthalmol, 2022, 22(1): 1-13.
|
[15] |
SONG S, YU X, ZHANG P, et al. Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy[J]. J Diabetes Complicat, 2020, 34(9): 107641.
|
1. |
魏静,白焕焕,徐红波,张海钢. 罗伊氏乳杆菌对脓毒症小鼠肠道保护机制的初步研究. 临床医学研究与实践. 2024(16): 45-49 .
![]() | |
2. |
谭学蓉,张莉,徐兰,李鲜,王嘉英,邹永蓉. 罗伊氏乳杆菌治疗早产儿喂养不耐受及预防医院感染的效果. 中华医院感染学杂志. 2022(04): 595-599 .
![]() |